Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
NPJ Biofilms and Microbiomes|January 6, 2026
Unraveling the microbial landscape in prostate cancer: pathogenesis to therapyXiancai Du, Jing Wu, Siyuan Xia, et al.Cancers|March 6, 2021
Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate CancerJun A, Baotong Zhang, Zhiqian Zhang, et al.IUBMB Life|February 2, 2018
The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathwayXinxin Tian, Fangfang Tao, Baotong Zhang, et al.Bio-Protocol|December 15, 2021
Measurement of Bone Metastatic Tumor Growth by a Tibial Tumorigenesis AssayBaotong Zhang, Xin Li, Wei-Ping Qian, et al.Frontiers in Oncology|October 27, 2022
Targeting aldehyde dehydrogenase for prostate cancer therapiesMiao Ma, Wenyou He, Keyu Zhao, et al.Tissue & Cell|December 22, 2024
Gbp2 driving macrophages dynamics in murine heart transplantBaotong Zhang, Wenbin Ji, Duowei Wang, et al.Cellular Immunology|July 2, 2021
The lncRNA PVT1 regulates autophagy in regulatory T cells to suppress heart transplant rejection in mice by targeting miR-146aJian Lu, Xiaodong Wang, Baotong Zhang, et al.Stem Cell Research & Therapy|November 4, 2023
sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitisWenbin Ji, Weiwei Wang, Peiyuan Li, et al.Transplant Immunology|May 21, 2021
Regulatory T cells induce transplant immune toleranceJian Lu, Peiyuan Li, Xuezhi Du, et al.Immunobiology|June 16, 2026
rFgl2-treated CD32b+M2 macrophages effectively inhibits cardiac transplant rejection in miceWenbin Ji, Baotong Zhang, Jiansheng Zhang, et al.Pageof 6